Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £26 | £27 | £32 | £33 |
| - Cash | £2 | £4 | £1 | £2 |
| + Debt | £1 | £1 | £1 | £1 |
| Enterprise Value | £25 | £25 | £31 | £32 |
| Revenue | £5 | £3 | £4 | £2 |
| % Growth | 72.4% | -16.9% | 54.6% | – |
| Gross Profit | £2 | £1 | £2 | £1 |
| % Margin | 41.4% | 29.6% | 60.7% | 53% |
| EBITDA | -£0 | -£2 | £0 | -£1 |
| % Margin | -8.9% | -75.2% | 7.1% | -37.4% |
| Net Income | -£1 | -£3 | -£0 | -£1 |
| % Margin | -16.8% | -81.5% | -1.8% | -50% |
| EPS Diluted | -0.002 | -0.007 | -0 | -0.004 |
| % Growth | 66.2% | -3,450% | 94.9% | – |
| Operating Cash Flow | -£1 | -£2 | -£0 | -£1 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£1 | -£2 | -£0 | -£1 |